Page last updated: 2024-11-04

sulfapyridine and Methemoglobinemia

sulfapyridine has been researched along with Methemoglobinemia in 1 studies

Sulfapyridine: Antibacterial, potentially toxic, used to treat certain skin diseases.
sulfapyridine : A sulfonamide consisting of pyridine with a 4-aminobenzenesulfonamido group at the 2-position.

Methemoglobinemia: The presence of methemoglobin in the blood, resulting in cyanosis. A small amount of methemoglobin is present in the blood normally, but injury or toxic agents convert a larger proportion of hemoglobin into methemoglobin, which does not function reversibly as an oxygen carrier. Methemoglobinemia may be due to a defect in the enzyme NADH methemoglobin reductase (an autosomal recessive trait) or to an abnormality in hemoglobin M (an autosomal dominant trait). (Dorland, 27th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lang, PG1

Other Studies

1 other study available for sulfapyridine and Methemoglobinemia

ArticleYear
Sulfones and sulfonamides in dermatology today.
    Journal of the American Academy of Dermatology, 1979, Volume: 1, Issue:6

    Topics: Agranulocytosis; Dapsone; Drug Hypersensitivity; Hemolysis; Humans; Kidney Diseases; Methemoglobinem

1979